Quantum Corporation (QMCO) Dividend History

Company News

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quantum Corporation - QMCO

  Pomerantz Law Firm is investigating potential securities fraud at Quantum Corporation following the resignation of its CFO Lewis Moorehead during an internal accounting review, which caused the company's stock to drop 8.2%.

  GlobeNewswire Inc.
• J.P. Morgan sees mixed signals in Check Point stock ahead of Q2 earnings - Investing.com

  J.P. Morgan maintained a neutral rating on Check Point Software Technologies (CHKP) stock, citing mixed signals ahead of the company's Q2 earnings. While positive on Check Point's valuation and cash flow, the firm is cautious due to execution challenges and the potential impact of the Quantum product cycle.

  Investing.com

  Featured Companies: CHKP
• Quantum (QMCO) Unveils Cutting-Edge Filesharing Technology

  Quantum (QMCO) adds a new filesharing technology to its Myriad and StorNext solutions. The technology is available as part of QMCO's broadened collaboration with Tuxera.

  Zacks Investment Research

  Featured Companies: NVDA PINS
• Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket

  Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Ainos, Inc. (NASDAQ: AIMD) gained 112.3% to $2.23 in pre-market trading. MSP Recovery, Inc. (NASDAQ: LIFW) shares rose 41.7% to $1.46 in pre-market trading. LifeWallet announced a comprehensive settlement with 28 affiliated property and casualty insurers, benefiting LifeWallet’s medicare clients across the U.S. Jaguar Health, Inc. (NASDAQ: JAGX) shares rose 37.8% to $0.1220 in pre-market trading after surging 50% on Friday. Renalytix Plc (NASDAQ: RNLX) gained 35.5% to $1.41 in pre-market trading. Renalytix recently announced that effective March 1, 2024, the United States Government has approved adding the company’s FDA de Novo Marketing authorized test, kidneyintelX.dkd, to its 10-year Governmentwide Acquisition Contract for early-stage kidney disease bioprognostic testing services. Aadi Bioscience, Inc. (NASDAQ: AADI) shares surged 20.8% to $2.32 in pre-market ...

  Benzinga

  Featured Companies: ADIL AIMD BBLG BIVI BTDR CMCL COCH DECK JAGX JL PHUN RELI SBFM SMCI
• 5 stocks under $5 to catch the small-cap rally as investors turn bullish

  The lowdown on small-caps: They're cheap and set up for a rebound.

  MarketWatch

  Featured Companies: DHX HGBL RBBN TURN VZ